Analyst consensus rating
Alamar Biosciences Analyst Rating: Buy
Direct answer
Alamar Biosciences's consensus rating is Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $37.00.
Forecast evidence checked November 13, 2026.
Get free Alamar Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $31.76
- Average price target
- $37.00
- High price target
- $45.00
- Low price target
- $34.00
- Low target gap
- +7.1%
- Target upside
- +16.5%
- High target gap
- +41.7%
- Target range width
- 34.6%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- November 13, 2026
- Valid through
- November 20, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Alamar Biosciences?
Alamar Biosciences has a verified Buy consensus. The same dataset has an average price target of $37.00.
How far are Alamar Biosciences's low and high targets from the recorded price?
The low target implies +7.1%, while the high target implies +41.7%.
How many analysts are included in Alamar Biosciences's consensus?
The verified consensus includes 5 analysts.
How is Alamar Biosciences's target upside or downside calculated?
The average target of $37.00 is divided by the recorded price of $31.76, then one is subtracted to produce +16.5%. This does not guarantee a future return.
When was Alamar Biosciences's analyst forecast verified?
The data was verified on 2026-11-13. The dataset is valid through 2026-11-20.